Health and Plant Protein Group Limited (HPP) AI Stock Analysis

• Market Cap: AU$5.16M
• Dividend Yield: N/A
• Average Volume (3M): 0.00
• Price to Earnings (P/E): ―
• Beta (1Y): -0.25
• Revenue Growth: N/A
• EPS Growth: 98.35%
• Country: AU
• Employees: 1
• Sector: Healthcare
• Sector Strength: 39
• Industry: Packaged Foods
• EPS (TTM): 0.00
• Shares Outstanding: 113,474,690
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 0
• PEG Ratio: 0.66
• Price to Book (P/B): 0.42
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -2.04
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 43 Neutral
• Price Target: ―

Health and Plant Protein Group Limited faces substantial financial and operational challenges. The absence of revenue, continued net losses, and negative cash flows are critical concerns. Although the company has no debt, declining assets and cash reserves pose risks to sustainability. The lack of market momentum or positive valuation factors further diminishes the stock's attractiveness.

Health and Plant Protein Group Limited Business Overview & Revenue Model

Company Description

Health and Plant Protein Group Limited (HPP) is a company engaged in the production and distribution of plant-based nutrition products. It operates within the health and wellness sector, focusing on providing high-quality plant protein and related products to meet the growing consumer demand for sustainable and healthy dietary options. HPP's core products include a range of plant-based protein ingredients and consumer-ready products designed to cater to health-conscious individuals and businesses seeking alternative protein sources.

How the Company Makes Money

HPP makes money primarily through the sale of its plant-based protein products. The company generates revenue by supplying plant protein ingredients to food manufacturers and retailers who incorporate these ingredients into their own products. Additionally, HPP develops and sells its own branded consumer products, which are distributed through various retail and online channels. Key revenue streams include bulk ingredient sales to other businesses and direct-to-consumer product sales. Strategic partnerships with food companies, retailers, and distributors enhance its market reach and contribute significantly to its earnings by expanding the availability and visibility of HPP's products in different regions.

Health and Plant Protein Group Limited Financial Statement Overview

Summary

Health and Plant Protein Group Limited is facing severe financial challenges, with zero revenue and ongoing net losses. Despite a debt-free balance sheet, the company's eroding asset base and negative cash flow signal significant financial instability.

Income Statement

Health and Plant Protein Group Limited has faced significant challenges in revenue generation, with total revenue dropping to zero in the latest fiscal year. The company has been experiencing negative net income consistently over recent years, reflecting ongoing profitability issues. The gross profit margin is non-existent due to the absence of revenue, and both EBIT and EBITDA margins are negative, indicating operational inefficiencies. The revenue growth trajectory has been negative, with a complete collapse from prior years' levels, which is a major concern for future prospects.

Balance Sheet

The balance sheet of the company shows a strong equity position with a positive stockholder's equity and no debt, which reflects financial stability. The equity ratio is relatively high, suggesting that the company is not reliant on debt financing. However, declining total assets and a significant reduction in cash reserves are potential red flags for long-term sustainability. The company's ability to leverage its assets effectively is questionable, and the trend of diminishing equity suggests potential future liquidity issues.

Cash Flow

The cash flow analysis reveals significant negative operating cash flow, indicating challenges in generating cash from core operations. There is no free cash flow growth, with consistently negative free cash flow, reflecting the company's inability to generate cash after capital expenditures. The operating cash flow to net income ratio is unfavorable, suggesting that the company's net income does not translate effectively into cash flow. The financial health is further strained by negative financing cash flow, which may limit future growth opportunities.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	-25.00K	0.00	0.00	42.25M	36.23M	42.12M
Gross Profit	-25.00K	0.00	-131.00K	11.79M	1.39M	9.88M
EBITDA	323.00K	226.00K	-2.79M	-1.15M	-9.76M	1.35M
Net Income	-96.00K	-801.00K	-16.83M	665.00K	-10.11M	-7.57M
Balance Sheet
Total Assets	6.23M	6.26M	8.56M	56.14M	49.95M	73.60M
Cash, Cash Equivalents and Short-Term Investments	904.00K	1.29M	3.75M	3.47M	2.73M	2.67M
Total Debt	0.00	0.00	0.00	21.18M	20.22M	27.79M
Total Liabilities	125.00K	112.00K	1.27M	31.09M	29.02M	47.21M
Stockholders Equity	6.11M	6.15M	7.29M	25.04M	20.93M	26.39M
Cash Flow
Free Cash Flow	-845.00K	-1.34M	-7.34M	576.00K	-3.54M	-292.00K
Operating Cash Flow	-845.00K	-1.34M	-7.34M	1.40M	-2.62M	860.00K
Investing Cash Flow	66.00K	-592.00K	16.71M	-948.00K	5.94M	-1.39M
Financing Cash Flow	-513.00K	-513.00K	-8.84M	297.00K	-3.16M	1.74M

Health and Plant Protein Group Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BGA	59 Neutral	€1.67B	48.84	3.35%	2.19%	4.28%	―
SHV	51 Neutral	$578.38M	17.54	7.05%	―	75.76%	―
Sector *	49 Neutral	AU$2.50B	4.42	-64.25%	2.77%	36.51%	13.14%
AHF	46 Neutral	€31.59M	―	-23.00%	―	-2.14%	11.40%
HPP	43 Neutral	AU$5.16M	―		―	―	98.35%
EAT	32 Underperform	AU$5.13M	―		―	7.02%	-44.64%

Health and Plant Protein Group Limited Corporate Events

Health and Plant Protein Group Limited Reports Reduced Losses Following Divestiture

Health and Plant Protein Group Limited reported a net loss after tax of $43,000 for the half-year ending 31 December 2024, a significant improvement from the $748,000 loss in the previous year. This improvement is largely due to the divestiture of its macadamia division, which halted business operations and led to the suspension of trading in HPP shares. The company is awaiting clearance of US$3.9 million from the IRS, with uncertainty over timing and amount due to processing delays. The half-year also saw a decrease in corporate overheads and an unrealized foreign exchange gain.

Health and Plant Protein Group Limited Releases Half-Year Report

Health and Plant Protein Group Limited has released its half-year report for the period ending December 31, 2024. The report highlights the company’s financial performance and operational updates, providing insights into its current state and strategic direction. While specific financial figures are not detailed, the report serves as a significant update for stakeholders regarding the company’s progress and market positioning.